Sponsor & Developer Portfolio
Bharat Biotech
Clinical development pipeline, platform architecture, and registered trial tracking for Bharat Biotech vaccine candidates.
3
Candidates
3
Target Diseases
3
Linked Studies
Development Phase Distribution
Phase 3 Clinical Trial: 1 Phase 2 Clinical Trial: 1 Discontinued / Inactive: 1
Platform Technologies
Biological (unspecified platform): 3
Target Pathogens & Indications
COVID-19 Rotavirus Tuberculosis
Vaccine Pipeline Candidates (3)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
Discontinued / Inactive
ctgov-equine-covid-19-antiserum-bharat-serums-and-vaccines-limited
Equine COVID-19 Antiserum
Target: COVID-19
Platform: Biological (unspecified platform)
Key Milestone: Primary completion (most advanced trial): 2022-05-25 (registry estimate)
Phase 2 Clinical Trial
ctgov-mtbvac-bharat-biotech-international-limited
MTBVAC
Target: Tuberculosis
Platform: Biological (unspecified platform)
Key Milestone: Primary completion (most advanced trial): 2025-09-01 (registry estimate)
Phase 3 Clinical Trial
ctgov-rotavac-5d-bharat-biotech-international-limited
ROTAVAC 5D
Target: Rotavirus
Platform: Biological (unspecified platform)
Key Milestone: Primary completion (most advanced trial): 2025-01-04 (registry estimate)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.